The accumulated experimental evidence so far indicates that such atypical immunoglobulins promote growth and proliferation of cancer cells [25,26], in turn suggesting that PIGR may regulate these immunoglobulins negatively in the majority of cancer forms, including upper gastrointestinal adenocarcinoma. This evidence concerns the gene PIGR and cancer.